The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
Open accessPublished version of a preprint
Abstract
The SARS-CoV-2 lineage B.1.1.7, designated variant of concern (VOC) 202012/01 by Public Health England 1, was first identified in the UK in late summer to early autumn 2020 2. Whole-genome SARS-CoV-2 sequence data collected from community-based diagnostic testing for COVID-19 show an extremely rapid expansion of the B.1.1.7 lineage during autumn 2020, suggesting that it has a selective advantage. Here we show that changes in VOC frequency inferred from genetic data correspond closely to changes inferred by S gene target failures (SGTF) in community-based diagnostic PCR testing. Analysis of trends in SGTF and non-SGTF case numbers in local areas across England shows that B.1.1.7 has higher transmissibility than non-VOC lineages, even if it has a different latent period or generation time. The SGTF data indicate a transient shift in the age composition of reported cases, with cases of B.1.1.7 including a larger share of under 20-year-olds than non-VOC cases. We estimated time-varying reproduction numbers for B.1.1.7 and co-circulating lineages using SGTF and genomic data. The best-supported models did not indicate a substantial difference in VOC transmissibility among different age groups, but all analyses agreed that B.1.1.7 has a substantial transmission advantage over other lineages, with a 50% to 100% higher reproduction number.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Epidemiological studies suggest that it was approximately 50% more transmissible than previously circulating UK variants 191,197,198 .”
From The biological and clinical significance of emerging SARS-CoV-2 variants (2021) · cites this paper as [191]
In the citing paper
“Volz and colleagues have shown that the B.1.1.7 variant increases the effective reproduction number, Rt, by a factor of 1·5–2·0.5”
From Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study (2021) · cites this paper as [5]
In the citing paper
“Preliminary evidence from epidemiological studies suggests that the B.1.1.7 variant is more transmissible than pre-existing variants.”
From Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study (2021) · cites this paper as [5]
In the citing paper
“In addition, the emergence of new variants with increased transmissibility 8 and reduced sensitivity to vaccine-elicited antibodies 9 , and for which vaccines are less able to prevent infection 10 , has raised fears for vulnerable groups in whom the magnitude and quality of immune responses may be suboptimal.”
From Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2 (2021) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Elements of Statistical Learning
Hastie, T., Tibshirani, R., & Friedman, J. (2009) · Springer Series in Statistics · doi:10.1007/978-0-387-84858-7 · Cited by 25,970
IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era
Minh, B. Q., Schmidt, H. A., Chernomor, O., Schrempf, D., Woodhams, M. D., von Haeseler, A., & Lanfear, R. (2020) · Molecular Biology and Evolution · doi:10.1093/molbev/msaa015 · Cited by 16,873
Hastie, T., & Tibshirani, R. (1986) · Statistical Science · doi:10.1214/ss/1177013604 · Cited by 12,575
Posterior summarization in Bayesian phylogenetics using tracer 1.7
Rambaut, A., Drummond, A. J., Xie, D., Baele, G., & Suchard, M. A. (2018) · Systematic Biology · doi:10.1093/sysbio/syy032 · Cited by 11,159
Self-citationBayesian phylogenetic and phylodynamic data integration using BEAST 1.10
Suchard, M. A., Lemey, P., Baele, G., Ayres, D. L., Drummond, A. J., & Rambaut, A. (2018) · Virus Evolution · doi:10.1093/ve/vey016 · Cited by 3,749
Self-citationEstimating the effects of non-pharmaceutical interventions on COVID-19 in Europe
Flaxman, S. R., Mishra, S., Gandy, A., Unwin, H. J. T., Mellan, T. A., Coupland, H., Whittaker, C., Zhu, H., Berah, T., Eaton, J. W., et al. (2020) · Nature · doi:10.1038/s41586-020-2405-7 · Cited by 3,398
Self-citationEstimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2021) · Science · doi:10.1126/science.abg3055 · Cited by 2,581
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2020) · doi:10.1101/2020.12.24.20248822 · Cited by 2,557
Detection of a SARS-CoV-2 variant of concern in South Africa
Tegally, H., Wilkinson, E., Giovanetti, M., Iranzadeh, A., Fonseca, V., Giandhari, J., Doolabh, D., Pillay, S., San, E. J., Msomi, N., et al. (2021) · Nature · doi:10.1038/s41586-021-03402-9 · Cited by 2,510
Bi, Q., Wu, Y., Mei, S., Ye, C., Zou, X., Zhang, Z., Liu, X., Wei, L., Truelove, S., Zhang, T., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30287-5 · Cited by 1,960
Cited by
Sorted by citations
Items 101–200 of 1,003
Fix, O. K., Blumberg, E. A., Chang, K., Chu, J., Chung, R. T., Goacher, E. K., Hameed, B., Kaul, D. R., Kulik, L., Kwok, R. M., et al. (2021) · Hepatology · doi:10.1002/hep.31751 · Cited by 157
Evaluation of COVID-19 vaccination strategies with a delayed second dose
Moghadas, S. M., VILCHES, T. N., Zhang, K., Nourbakhsh, S., Sah, P., Fitzpatrick, M. C., & Galvani, A. P. (2021) · PLoS Biology · doi:10.1371/journal.pbio.3001211 · Cited by 154
Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy
Ramesh, S., Govindarajulu, M., Parise, R. S., Neel, L. T., Shankar, T., Patel, S., Lowery, P., Smith, F., Dhanasekaran, M., & Moore, T. (2021) · Vaccines · doi:10.3390/vaccines9101195 · Cited by 157
An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants
Chan, K. K., Tan, T. J. C., Narayanan, K. K., & Procko, E. (2021) · Science Advances · doi:10.1126/sciadv.abf1738 · Cited by 152
SARS-CoV-2 one year on: evidence for ongoing viral adaptation
Peacock, T. P., Penrice-Randal, R., Hiscox, J. A., & Barclay, W. (2021) · Journal of General Virology · doi:10.1099/jgv.0.001584 · Cited by 155
Tada, T., Dcosta, B. M., Samanovic, M. I., Herati, R. S., Cornelius, A. R., Zhou, H., Vaill, A., Kazmierski, W., Mulligan, M. J., & Landau, N. R. (2021) · mBio · doi:10.1128/mbio.00696-21 · Cited by 155
Attwood, S. W., Hill, S. C., Aanensen, D. M., Connor, T. R., & Pybus, O. G. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00483-8 · Cited by 154
Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function
Yang, T., Yu, P., Chang, Y., Liang, K.-H., Tso, H.-C., Ho, M., Wy, C., Lin, H.-T., Wu, H., & Hsu, S. D. (2021) · Nature Structural & Molecular Biology · doi:10.1038/s41594-021-00652-z · Cited by 167
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19
Kreuzberger, N., Hirsch, C., Chai, K. L., Tomlinson, E., Khosravi, Z., Popp, M., Neidhardt, M., Piechotta, V., Salomon, S., Valk, S. J., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013825.pub2 · Cited by 153
The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK
Hill, V., du Plessis, L., Peacock, T. P., Aggarwal, D., Colquhoun, R., Carabelli, A. M., Ellaby, N. A. F., Gallagher, E., Groves, N., Jackson, B., et al. (2022) · Virus Evolution · doi:10.1093/ve/veac080 · Cited by 145
Self-citationEvolutionary trajectory of SARS-CoV-2 and emerging variants
Singh, J., Pandit, P., McArthur, A. G., Banerjee, A., & Mossman, K. L. (2021) · Virology Journal · doi:10.1186/s12985-021-01633-w · Cited by 150
COVID-19 in patients with hematologic malignancy
Langerbeins, P., & Hallek, M. J. (2022) · Blood · doi:10.1182/blood.2021012251 · Cited by 143
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Sun, C., Xie, C., Bu, G., Zhong, L., & Zeng, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01039-2 · Cited by 149
Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
Becker, M., Dulovic, A., Junker, D., Ruétalo, N., Kaiser, P. D., Pinilla, Y. T., Heinzel, C., Häring, J., Traenkle, B., Wagner, T. R., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23473-6 · Cited by 137
Characterization of the Second Wave of COVID-19 in India
Ranjan, R., Sharma, A., & Verma, M. K. (2021) · Current Science · doi:10.18520/cs/v121/i1/85-93 · Cited by 139
Kang, M., Xin, H., Yuan, J., Ali, S. T., Liang, Z., Zhang, J., Hu, T., Lau, E. H. Y., Zhang, Y., Zhang, M., et al. (2022) · Eurosurveillance · doi:10.2807/1560-7917.es.2022.27.10.2100815 · Cited by 139
Moriyama, S., Adachi, Y., Sato, T., Tonouchi, K., Sun, L., Fukushi, S., Yamada, S., Kinoshita, H., Nojima, K., Kanno, T., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.06.015 · Cited by 140
Key epidemiological drivers and impact of interventions in the 2020 SARS-CoV-2 epidemic in England
Knock, E., Whittles, L. K., Lees, J. A., Perez‐Guzman, P. N., Verity, R., FitzJohn, R. G., Gaythorpe, K. A. M., Imai, N., Hinsley, W. R., Okell, L., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abg4262 · Cited by 135
Self-citationde Vries, M., Mohamed, A., Prescott, R. A., Valero-Jimenez, A. M., Desvignes, L., O’Connor, R., Steppan, C. M., Devlin, J. C., Ivanova, E. N., Herrera, A. M., et al. (2021) · Journal of Virology · doi:10.1128/jvi.01819-20 · Cited by 137
Controlling the pandemic during the SARS-CoV-2 vaccination rollout
Viana, J., van Dorp, C. H., Nunes, A., Gomes, M. C., van Boven, M., Kretzschmar, M., Veldhoen, M., & Rozhnova, G. (2021) · Nature Communications · doi:10.1038/s41467-021-23938-8 · Cited by 136
Li, W., Chen, Y., Prévost, J., Ullah, I., Lu, M., Gong, S. Y., Tauzin, A., Gasser, R., Vézina, D., Anand, S. P., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110210 · Cited by 128
Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis
Nyberg, T., Twohig, K. A., Harris, R., Seaman, S. R., Flannagan, J., Allen, H., Charlett, A., Angelis, D. D., Dabrera, G., & Presanis, A. M. (2021) · Apollo (University of Cambridge) · doi:10.17863/cam.71427 · Cited by 131
Self-citationPredictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people
Elliott, J., Whitaker, M. D., Bodinier, B., Eales, O. D., Riley, S., Ward, H., Cooke, G., Darzi, A. W., Chadeau‐Hyam, M., & Elliott, P. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003777 · Cited by 127
Context-specific emergence and growth of the SARS-CoV-2 Delta variant
McCrone, J. T., Hill, V., Bajaj, S., Pena, R. E., Lambert, B. C., Inward, R. P. D., Bhatt, S., Volz, E., Ruis, C., Dellicour, S., et al. (2022) · Nature · doi:10.1038/s41586-022-05200-3 · Cited by 128
Self-citationEarly introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States
Alpert, T., Brito, A. F., Lasek‐Nesselquist, E., Rothman, J. E., Valesano, A. L., MacKay, M. J., Petrone, M. E., Breban, M. I., Watkins, A. E., Vogels, C. B. F., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.061 · Cited by 122
Superspreading drives the COVID pandemic — and could help to tame it
Lewis, D. (2021) · Nature · doi:10.1038/d41586-021-00460-x · Cited by 123
Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants
Mittal, A., Khattri, A., & Verma, V. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010260 · Cited by 124
A look into the future of the COVID-19 pandemic in Europe: an expert consultation [viewpoint].
Iftekhar, E. N., Priesemann, V., Balling, R., Bauer, S., Beutels, P., Valdez, A. S. C., Cuschieri, S., Czypionka, T., Dumpis, U., Glaab, E., et al. (2021) · BORIS (University Library Bern) · doi:10.17863/cam.75145 · Cited by 119
Brown, K. A., Gubbay, J. B., Hopkins, J. P., Patel, S. N., Buchan, S. A., Daneman, N., & Goneau, L. W. (2021) · JAMA · doi:10.1001/jama.2021.5607 · Cited by 116
Impaired detection of omicron by SARS-CoV-2 rapid antigen tests
Osterman, A., Badell, I., Basara, E., Stern, M., Kriesel, F., Eletreby, M., Öztan, G. N., Huber, M., Autenrieth, H., Knabe, R., et al. (2022) · Medical Microbiology and Immunology · doi:10.1007/s00430-022-00730-z · Cited by 118
SARS-CoV-2: Evolution and Emergence of New Viral Variants
Flores-Vega, V. R., Monroy-Molina, J. V., Jiménez-Hernández, L. E., Torres, A. G., Santos, J. I., & Rosales-Reyes, R. (2022) · Viruses · doi:10.3390/v14040653 · Cited by 127
Accelerated SARS-CoV-2 intrahost evolution leading to distinct genotypes during chronic infection
Chaguza, C., Hahn, A. M., Petrone, M. E., Zhou, S., Ferguson, D. J. P., Breban, M. I., Pham, K., Peña-Hernández, M. A., Castaldi, C., Hill, V., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.100943 · Cited by 123
Self-citationChakraborty, C., Bhattacharya, M., & Sharma, A. R. (2022) · Reviews in Medical Virology · doi:10.1002/rmv.2270 · Cited by 111
Chen, X., Chen, Z., Azman, A. S., Sun, R., Lu, W., Zheng, N., Zhou, J., Wu, Q., Deng, X., Zhao, Z., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab646 · Cited by 113
Changing composition of SARS-CoV-2 lineages and rise of Delta variant in England
Mishra, S., Mindermann, S., Sharma, M., Whittaker, C., Mellan, T. A., Wilton, T., Klapsa, D., Mate, R., Fritzsche, M., Zambon, M. C. F. A., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101064 · Cited by 109
Self-citationDroplet digital RT-PCR to detect SARS-CoV-2 signature mutations of variants of concern in wastewater
Heijnen, L., Elsinga, G., de Graaf, M., Molenkamp, R., Koopmans, M., & Medema, G. J. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.149456 · Cited by 109
Hodcroft, E. B., Domman, D., Snyder, D. J., Oguntuyo, K. Y., Diest, M. V., Densmore, K. H., Schwalm, K. C., Femling, J., Carroll, J. L., Scott, R. S., et al. (2021) · medRxiv · doi:10.1101/2021.02.12.21251658 · Cited by 110
Emergence and spread of a SARS-CoV-2 lineage A variant (A.23.1) with altered spike protein in Uganda
Bugembe, D. L., Phan, M. V. T., Ssewanyana, I., Semanda, P., Nansumba, H., Dhaala, B., Nabadda, S. N., O’Toole, Á., Rambaut, A., Kaleebu, P., et al. (2021) · Nature Microbiology · doi:10.1038/s41564-021-00933-9 · Cited by 104
Self-citationGushchin, V. А., Dolzhikova, I. V., Shchetinin, A. M., Odintsova, A. S., Siniavin, A. E., Nikiforova, M. A., Pochtovyi, A. A., Shidlovskaya, E. V., Kuznetsova, N. A., Burgasova, O., et al. (2021) · Vaccines · doi:10.3390/vaccines9070779 · Cited by 110
Liu, Z., Zhou, J., Xu, W., Deng, W., Wang, Y., Wang, M., Wang, Q., Hsieh, M. K., Dong, J., Wang, X., et al. (2022) · Cell Research · doi:10.1038/s41422-022-00612-2 · Cited by 113
Replication kinetics and infectivity of SARS-CoV-2 variants of concern in common cell culture models
Mautner, L., Hoyos, M., Dangel, A., Berger, C., Ehrhardt, A., & Baiker, A. E. (2022) · Virology Journal · doi:10.1186/s12985-022-01802-5 · Cited by 107
Recent developments in the immunopathology of COVID ‐19
Zhang, H., Sun, Y., Wang, Y., Yazıcı, D., Azkur, D., Öğülür, İ., Azkur, A. K., Yang, Z., Chen, X., Zhang, A., et al. (2022) · Allergy · doi:10.1111/all.15593 · Cited by 115
An action plan for pan-European defence against new SARS-CoV-2 variants
Priesemann, V., Balling, R., Brinkmann, M. M., Ciesek, S., Czypionka, T., Eckerle, I., Giordano, G., Hanson, C., Hel, Z., Hotulainen, P., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00150-1 · Cited by 107
Dyson, L., Hill, E. M., Moore, S., Curran-Sebastian, J. L., Tildesley, M. J., Lythgoe, K., House, T., Pellis, L., & Keeling, M. J. (2021) · Nature Communications · doi:10.1038/s41467-021-25915-7 · Cited by 104
Genomic reconstruction of the SARS-CoV-2 epidemic in England
Vöhringer, H. S., Sanderson, T., Sinnott, M., Maio, N. D., Nguyen, T., Goater, R., Schwach, F., Harrison, I., Hellewell, J., Ariani, C. V., et al. (2021) · Nature · doi:10.1038/s41586-021-04069-y · Cited by 108
Self-citationTrack Omicron’s spread with molecular data
Scott, L. E., Hsiao, M., Moyo, S., Singh, L., Tegally, H., Dor, G., Maes, P., Pybus, O. G., Kraemer, M. U. G., Semenova, E., et al. (2021) · Science · doi:10.1126/science.abn4543 · Cited by 109
Self-citationAn update on COVID-19: SARS-CoV-2 variants, antiviral drugs, and vaccines
Hillary, V. E., & Ceasar, S. A. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13952 · Cited by 121
Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variant
Thorne, L. G., Bouhaddou, M., Reuschl, A.-K., Zuliani-Alvarez, L., Polacco, B., Pelin, A., Batra, J., Whelan, M. V. X., Ummadi, M., Rojc, A., et al. (2021) · doi:10.1101/2021.06.06.446826 · Cited by 91
Accelerated vaccine rollout is imperative to mitigate highly transmissible COVID-19 variants
Sah, P., VILCHES, T. N., Moghadas, S. M., Fitzpatrick, M. C., Singer, B. H., Hotez, P. J., & Galvani, A. P. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100865 · Cited by 108
Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects
Jennewein, M. F., MacCamy, A. J., Akins, N. R., Feng, J., Homad, L. J., Hurlburt, N. K., Seydoux, E., Wan, Y.-H., Stuart, A. B., Edara, V. V., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109353 · Cited by 108
Beumer, J., Geurts, M. H., Lamers, M. M., Puschhof, J., Zhang, J., van der Vaart, J., Mykytyn, A. Z., Breugem, T. I., Riesebosch, S., Schipper, D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25729-7 · Cited by 113
SARS-CoV-2, CT-Values, and Infectivity—Conclusions to Be Drawn from Side Observations
Platten, M., Hoffmann, D., Grosser, R., Wisplinghoff, F., Wisplinghoff, H., Wiesmüller, G. A., Schildgen, O., & Schildgen, V. (2021) · Viruses · doi:10.3390/v13081459 · Cited by 109
HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens
Fischer, W., Giorgi, E. E., Chakraborty, S., Nguyen, K., Tanmoy Bhattacharya, A., Theiler, J. P., Goloboff, P. A., Yoon, H., Abfalterer, W., Foley, B. T., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.05.012 · Cited by 109
Dupont, L., Snell, L. B., Graham, C., Seow, J., Merrick, B., Lechmere, T., Maguire, T. J. A., Hallett, S. R., Pickering, S., Charalampous, T., et al. (2021) · Nature Microbiology · doi:10.1038/s41564-021-00974-0 · Cited by 102
Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta
Ulrich, L., Halwe, N. J., Taddeo, A., Ebert, N., Schön, J., Devisme, C., Trüeb, B. S., Hoffmann, B., Wider, M., Fan, X., et al. (2021) · Nature · doi:10.1038/s41586-021-04342-0 · Cited by 98
Insights into new-onset autoimmune diseases after COVID-19 vaccination
Guo, M., Liu, X., Chen, X., & Li, Q. (2023) · Autoimmunity Reviews · doi:10.1016/j.autrev.2023.103340 · Cited by 113
Partial resistance of SARS-CoV-2 Delta variants to vaccine-elicited antibodies and convalescent sera
Tada, T., Zhou, H., Dcosta, B. M., Samanovic, M. I., Mulligan, M. J., & Landau, N. R. (2021) · iScience · doi:10.1016/j.isci.2021.103341 · Cited by 101
Natural and Experimental SARS-CoV-2 Infection in Domestic and Wild Animals
Meekins, D. A., Gaudreault, N. N., & Richt, J. A. (2021) · Viruses · doi:10.3390/v13101993 · Cited by 105
Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2
Firouzabadi, N., Ghasemiyeh, P., Moradishooli, F., & Mohammadi‐Samani, S. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109968 · Cited by 102
Intra-host evolution during SARS-CoV-2 prolonged infection
Voloch, C. M., Francisco, R. D. S., de Almeida, L. G. P., Brustolini, O. J. B., Cardoso, C. C., Gerber, A. L., Guimarães, A. P. D. C., Leitão, I. D. C., Mariani, D., Ota, V. A., et al. (2021) · Virus Evolution · doi:10.1093/ve/veab078 · Cited by 99
Tauzin, A., Gong, S. Y., Beaudoin-Bussières, G., Vézina, D., Gasser, R., Nault, L., Marchitto, L., Benlarbi, M., Chatterjee, D., Nayrac, M., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.12.004 · Cited by 106
The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern
Akkız, H. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.849217 · Cited by 102
(2021) · doi:10.1016/j.vaccine.2021.04.002 · Cited by 101
Self-citationEmergence of immune escape at dominant SARS-CoV-2 killer T cell epitope
Dolton, G. M., Rius, C., Hasan, M. S., Wall, A., Szomolay, B., Behiry, E. M., Whalley, T., Southgate, J., Fuller, A., Morin, T., et al. (2022) · Cell · doi:10.1016/j.cell.2022.07.002 · Cited by 100
Pascarella, S., Ciccozzi, M., Zella, D., Bianchi, M., Benedetti, F., Benvenuto, D., Broccolo, F., Cauda, R., Caruso, A., Angeletti, S., et al. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27210 · Cited by 100
Role of COVID-19 Vaccines in SARS-CoV-2 Variants
Zhou, Z., Zhu, Y., & Chu, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.898192 · Cited by 115
SARS-CoV-2 genomics: An Indian perspective on sequencing viral variants
Srivastava, S., Banu, S., Singh, P., Sowpati, D. T., & Mishra, R. K. (2021) · Journal of Biosciences · doi:10.1007/s12038-021-00145-7 · Cited by 96
Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape
Bushman, M., Kahn, R. J., Taylor, B. P., Lipsitch, M., & Hanage, W. P. (2021) · Cell · doi:10.1016/j.cell.2021.11.026 · Cited by 93
Liu, J., Bodnar, B. H., Meng, F., Khan, A. I., Wang, X., Luo, G. G., Saribas, S., Wang, T., Lohani, S. C., Wang, P., et al. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00680-8 · Cited by 97
Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis
Nyberg, T., Twohig, K. A., Harris, R., Seaman, S. R., Flannagan, J., Allen, H., Charlett, A., Angelis, D. D., Dabrera, G., & Presanis, A. M. (2021) · BMJ · doi:10.1136/bmj.n1412 · Cited by 133
Self-citationIncreased transmissibility of SARS-CoV-2 lineage B.1.1.7 by age and viral load
Lyngse, F. P., Mølbak, K., Skov, R. L., Christiansen, L. E., Mortensen, L. H., Albertsen, M., Møller, C. H., Krause, T. G., Rasmussen, M., Michaelsen, T. Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27202-x · Cited by 88
Gaythorpe, K. A. M., Bhatia, S., Mangal, T. D., Unwin, H. J. T., Imai, N., Cuomo-Dannenburg, G., Walters, C. E., Jauneikaite, E., Bayley, H., Kont, M. D., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-92500-9 · Cited by 94
Self-citationThe Emergence and Evolution of SARS-CoV-2
Holmes, E. C. (2024) · Annual Review of Virology · doi:10.1146/annurev-virology-093022-013037 · Cited by 96
Wang, H., Miller, J. A., Verghese, M., Sibai, M., Solis, D., Mfuh, K. O., Jiang, B., Iwai, N., Mar, M., Huang, C., et al. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00859-21 · Cited by 93
Tsuji, S., Minami, S., Hashimoto, R., Konishi, Y., Suzuki, T., Kondo, T., Sasai, M., Torii, S., Ono, C., Shichinohe, S., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00170-7 · Cited by 84
Were pregnant women more affected by COVID-19 in the second wave of the pandemic?
Kadiwar, S., Smith, J. J., Ledot, S., Johnson, M., Bianchi, P. A., Singh, N., Montanaro, C., Gatzoulis, M., Shah, N. M., & Ukor, E.-F. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00716-9 · Cited by 92
Averting an Outbreak of SARS-CoV-2 in a University Residence Hall through Wastewater Surveillance
Corchis-Scott, R., Geng, Q., Seth, R., Ray, R., Beg, M. R., Biswas, N., Charron, L., Drouillard, K., D’Souza, R., Heath, D. D., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00792-21 · Cited by 92
Eggink, D., Andeweg, S. P., Vennema, H., van Maarseveen, N. M., Vermaas, K., Vlaemynck, B., Schepers, R., van Gageldonk-Lafeber, A. B., van den Hof, S., Reusken, C. B. E. M., et al. (2022) · Eurosurveillance · doi:10.2807/1560-7917.es.2022.27.4.2101196 · Cited by 89
Martin, D. P., Weaver, S., Tegally, H., San, E. J., Shank, S. D., Wilkinson, E., Lucaci, A. G., Giandhari, J., Naidoo, S., Pillay, Y., et al. (2021) · doi:10.1101/2021.02.23.21252268 · Cited by 291
SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?
Chakraborty, S., Mallajosyula, V. V. A., Tato, C. M., Tan, G. S., & Wang, T. T. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.014 · Cited by 90
Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variants
Zhang, L., Dutta, S., Xiong, S., Chan, M. C., Chan, K. K., Fan, T. M., Bailey, K. L., Lindeblad, M. O., Cooper, L. M., Rong, L., et al. (2022) · Nature Chemical Biology · doi:10.1038/s41589-021-00965-6 · Cited by 87
Tian, J., Sun, J., Li, D., Wang, N., Wang, L., Zhang, C., Meng, X., Ji, X., Suchard, M. A., Zhang, X., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110969 · Cited by 98
Kumar, M., Gulati, S., Ansari, A. H., Phutela, R., Acharya, S., Azhar, M., Murthy, J., Kathpalia, P., Kanakan, A., Maurya, R., et al. (2021) · eLife · doi:10.7554/elife.67130 · Cited by 88
Predicting the zoonotic capacity of mammals to transmit SARS-CoV-2
Fischhoff, I. R., Castellanos, A. A., Rodrigues, J., Varsani, A., & Han, B. A. (2021) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2021.1651 · Cited by 90
Choudhary, M. C., Crain, C. R., Qiu, X., Hanage, W. P., & Li, J. Z. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab380 · Cited by 82
Borges, V., Sousa, C., Menezes, L., Gonçalves, A. M., Picão, M., Almeida, J. P., Vieita, M., Santos, R., Silva, A. R., Costa, M., et al. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.10.2100130 · Cited by 73
Flisiak, R., Horban, A., Jaroszewicz, J., Kozielewicz, D., Mastalerz–Migas, A., Owczuk, R., Parczewski, M., Pawłowska, M., Piekarska, A., Simon, K. A., et al. (2021) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.15979 · Cited by 90
Progress and challenges in virus genomic epidemiology
Hill, V., Ruis, C., Bajaj, S., Pybus, O. G., & Kraemer, M. U. G. (2021) · Trends in Parasitology · doi:10.1016/j.pt.2021.08.007 · Cited by 88
Self-citationSun, W., He, L., Zhang, H., Tian, X., Bai, Z., Sun, L., Yang, L., Jia, X., Bi, Y., Luo, T., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00750-w · Cited by 83
Perinatal SARS-CoV-2 Infection and Neonatal COVID-19: A 2021 Update
Sankaran, D., Nakra, N. A., Cheema, R., Blumberg, D. A., & Lakshminrusimha, S. (2021) · NeoReviews · doi:10.1542/neo.22-5-e284 · Cited by 85
Predicted dominance of variant Delta of SARS-CoV-2 before Tokyo Olympic Games, Japan, July 2021
Ito, K., Piantham, C., & Nishiura, H. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.27.2100570 · Cited by 82
Wang, W. B., Liang, Y., Jin, Y. Q., Zhang, J., Su, J. G., & Li, Q. M. (2021) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2021.108035 · Cited by 83
Salleh, M. Z., Derrick, J. P., & Deris, Z. Z. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147425 · Cited by 82
Increased small particle aerosol transmission of B.1.1.7 compared with SARS-CoV-2 lineage A in vivo
Port, J. R., Yinda, C. K., Avanzato, V. A., Schulz, J. E., Holbrook, M. G., van Doremalen, N., Shaia, C., Fischer, R. J., & Munster, V. J. (2022) · Nature Microbiology · doi:10.1038/s41564-021-01047-y · Cited by 77
Rotondo, J. C., Martini, F., Maritati, M., Mazziotta, C., Mauro, G. D., Lanzillotti, C., Barp, N., Gallerani, A., Tognon, M. G., & Contini, C. (2021) · Viruses · doi:10.3390/v13091687 · Cited by 81
CRISPR-Cas12a-Based Detection for the Major SARS-CoV-2 Variants of Concern
Liang, Y., Lin, H., Zou, L., Zhao, J., Li, B., Wang, H., Lu, J., Sun, J., Yang, X., Deng, X., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.01017-21 · Cited by 78
Karita, H. C. S., Dong, T. Q., Johnston, C., Neuzil, K. M., Paasche‐Orlow, M. K., KISSINGER, P. J., Bershteyn, A., Thorpe, L. E., Deming, M. E., Kottkamp, A. C., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.42796 · Cited by 79
Mlcochova, P., Kemp, S., Dhar, M. S., Papa, G., Meng, B., Mishra, S., Whittaker, C., Mellan, T., Ferreira, I., Datir, R., et al. (2021) · doi:10.1101/2021.05.08.443253 · Cited by 90
Self-citationBrown, J. C., Goldhill, D. H., Zhou, J., Peacock, T. P., Frise, R., Goonawardane, N., Baillon, L., Kugathasan, R., Pinto, A., McKay, P. F., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.24.432576 · Cited by 70
Advances in the design and development of SARS-CoV-2 vaccines
Peng, X., Cheng, J., Gong, H., Yuan, M.-D., Zhao, X., Li, Z., & Wei, D. (2021) · Military Medical Research · doi:10.1186/s40779-021-00360-1 · Cited by 84
Metadata
- Authors
- The COVID-19 Genomics UK (COG-UK) consortium, Volz, E., Mishra, S., Chand, M., Barrett, J. C., Johnson, R., Geidelberg, L., Hinsley, W. R., Laydon, D. J., Dabrera, G., O’Toole, Á., Amato, R., Ragonnet-Cronin, M., Harrison, I., Jackson, B., Ariani, C. V., Boyd, O., Loman, N. J., McCrone, J. T., Gonçalves, S., Jorgensen, D., Myers, R., Hill, V., Jackson, D. K., Gaythorpe, K., Groves, N., Sillitoe, J., Kwiatkowski, D. P., Flaxman, S., Ratmann, O., Bhatt, S., Hopkins, S., Gandy, A., Rambaut, A., & Ferguson, N. M.
- Affiliations
- Imperial College London (GB)
- Public Health England (GB)
- Wellcome Sanger Institute (GB)
- University of Edinburgh (GB)
- University of Copenhagen (DK)
- Corresponding author
- Volz, Erik
- Ferguson, Neil M.
- ORCID
- Volz, Erik
- Mishra, Swapnil
- Chand, Meera
- Barrett, Jeffrey C.
- Geidelberg, Lily
- Hinsley, Wes R.
- Laydon, Daniel J.
- Dabrera, Gavin
- Harrison, Ian
- Jackson, Ben
- Ariani, Cristina V.
- Boyd, Olivia
- Loman, Nicholas J.
- McCrone, John T.
- Gonçalves, Sónia
- Jorgensen, David
- Myers, Richard
- Hill, Verity
- Jackson, David K.
- Gaythorpe, Katy
- Groves, Natalie
- Kwiatkowski, Dominic P.
- Flaxman, Seth
- Ratmann, Oliver
- Bhatt, Samir
- Hopkins, Susan
- Gandy, Axel
- Rambaut, Andrew
- Ferguson, Neil M.
- Venue
- Nature
- Published
- 2021-03-25
- Volume
- 593
- Issue
- 7858
- Pages
- 266-269
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W3136588845
- Cited by
- 1,611
- References
- 32
- Citations by year
- 2026: 38 · 2025: 86 · 2024: 116 · 2023: 216 · 2022: 464 · 2021: 685
- FWCI
- 116.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Nature (publishedVersion)
- medRxiv (acceptedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Northumbria Research Link (Northumbria University) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- Bill and Melinda Gates Foundation (OPP 1175094, 206194, OPP1197730, MR/R015600/1, OPP1084362)
- Wellcome Trust (MR/R015600/1, 204911/Z/16/Z, Z/17/Z, 206298/Z/17/Z, RDA02, 206298, 206194)
- UK Research and Innovation (MR/V038109/1, MR/R015600/1, MC_PC_19027)
- National Institute for Health Research Health Protection Research Unit
- Cancer Research UK (23923)
- National Institute for Health and Care Research (PR-OD-1017–20002, MR/R015600/1, RDA02, NIHR301445, OPP1175094, ACF-2018-04-014)
- Academy of Medical Sciences (AMS-CSF4-Torok, SBF004\1080)
- Imperial College London (MR/R015600/1)
- European Commission (725422, MR/R015600/1, 101003653, COVID-19, 206298/Z/17/Z)
- Rural Development Administration
- Novo Nordisk (NNF20OC0059309)
- Novo Nordisk Fonden (NNF20OC0059309)
- Medical Research Council (MR/R015600/1, MR/M006212/1, MC_PC_19026, MR/V038109/1, MR/S00291X/1, MC_PC_19012, COVID-19)
- Engineering and Physical Sciences Research Council (EP/V002910/1, EP/V002910/2)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
- Keywords
- SARS-CoV-2, B.1.1.7 lineage, variants of concern, transmissibility, S-gene target failure, time-varying reproduction number, viral genomic surveillance, COVID-19 pandemic, England
- MeSH terms
- COVID-19, SARS-CoV-2, Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, England, Humans, Infant, Infant, Newborn, Middle Aged, Phylogeny, Time Factors, Genome, Viral, Age Distribution, Evolution, Molecular, Basic Reproduction Number, Young Adult, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
